Therefore, considering VEGF expression alone has a limited value in prostate cancer and according to our results, it seems that considering a combination of PSA and a proper cut-off point for VEGF might result in overcoming such drawbacks. This evidence concerns the gene VEGFA and Familial prostate cancer.